Earlier this year at the BioPharma Asia Convention, Hiro Sugii, VP and Head of CMR division Japan & Korea, Novo Nordisk delivered the presentation âA pharma perspective: Assessing challenge and opportunity in expanding clinical development beyond Japan. Innovative R&D, why not?'
The outline of this presentation is as follows:
- Latest situation of Japanese Regulatory Affairs
- Understanding the pro-active globalization of Japanese pharmaceuticals for the expansion to emerging markets
- Exploring new business models to achieve organic growth beyond borders
- Case Study: Innovation in R&D for sustainable clinical development
The BioPharma Asia Convention is taking place again in March next year, for more information visit the event website by clicking here >